Regression of an acral lentiginous melanoma with an immunotherapy using a Mycobacterium tuberculosis-extracted polysaccharide complex (Tubercin).
Chung
Tai Ho
TH
WHO Collaboration Viral Hepatitis Center, Department of Dermatology, School of Medicine, Kyungpook National University, Dong-In Dong, Korea. ccchan61@unitel.co.kr
Jun
Jae Bok
JB
Jang
Jae Won
JW
Chung
Hai Lee
HL
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000368:Aged; D001426:Bacterial Proteins / Q000627:therapeutic use*; D005260:Female; D005385:Fingers; D006801:Humans; D007167:Immunotherapy; D008545:Melanoma / Q000628:therapy*; D009169:Mycobacterium tuberculosis; D012878:Skin Neoplasms / Q000628:therapy*
D000276:Adjuvants, Immunologic; D001426:Bacterial Proteins; C015564:tubercin-3